Cargando…
EGCG impedes human Tau aggregation and interacts with Tau
Tau aggregation and accumulation is a key event in the pathogenesis of Alzheimer’s disease. Inhibition of Tau aggregation is therefore a potential therapeutic strategy to ameliorate the disease. Phytochemicals are being highlighted as potential aggregation inhibitors. Epigallocatechin-3-gallate (EGC...
Autores principales: | Sonawane, Shweta Kishor, Chidambaram, Hariharakrishnan, Boral, Debjyoti, Gorantla, Nalini Vijay, Balmik, Abhishek Ankur, Dangi, Abha, Ramasamy, Sureshkumar, Marelli, Udaya Kiran, Chinnathambi, Subashchandrabose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387440/ https://www.ncbi.nlm.nih.gov/pubmed/32724104 http://dx.doi.org/10.1038/s41598-020-69429-6 |
Ejemplares similares
-
Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6
por: Dangi, Abha, et al.
Publicado: (2020) -
Correction: Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6
por: Dangi, Abha, et al.
Publicado: (2022) -
The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau
por: Balmik, Abhishek Ankur, et al.
Publicado: (2021) -
Basic Limonoid modulates Chaperone-mediated Proteostasis and dissolve Tau fibrils
por: Gorantla, Nalini Vijay, et al.
Publicado: (2020) -
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
por: Balmik, Abhishek Ankur, et al.
Publicado: (2021)